পদ্ধতির তুলনা করুন
নির্বাচিত পদ্ধতিগুলো পাশাপাশি পর্যালোচনা করুন; যে সারিগুলোয় পার্থক্য আছে সেগুলো চিহ্নিত করা হয়।
| SCORAD Index (SCORing Atopic Dermatitis)× | EASI (একজিমা এরিয়া অ্যান্ড সিভিয়ারিটি ইনডেক্স)× | |
|---|---|---|
| ক্ষেত্র | ত্বকবিজ্ঞান | ত্বকবিজ্ঞান |
| পরিবার | Process / pipeline | Process / pipeline |
| উদ্ভবের বছর≠ | 1993 | 2001 |
| প্রবর্তক≠ | European Task Force on Atopic Dermatitis (ETFAD) | Hanifin JM, Thurston M |
| ধরন | Clinician-rated | Clinician-rated |
| মৌলিক উৎস≠ | Kunz B, Oranje AP, Labrèze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10-19. DOI ↗ | Hanifin JM, Thurston M, Omoto M, et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Experimental Dermatology. 2001;10(1):11-18. DOI ↗ |
| অপর নাম | SCORAD Index | EASI Index |
| সম্পর্কিত≠ | 3 | 2 |
| সারসংক্ষেপ≠ | The SCORAD is a comprehensive clinician-administered tool for measuring the extent and severity of atopic dermatitis (eczema). Developed by the European Task Force on Atopic Dermatitis in 1993, it combines objective clinical assessment with subjective symptom reporting. It is the gold standard for atopic dermatitis severity in clinical trials and dermatology practice. | The EASI is a structured, clinician-administered tool for assessing the extent and intensity of atopic dermatitis across the body. Developed by Hanifin and colleagues in 2001, it divides the body into four regions with weighted area factors, ensuring proportional contribution to total score. EASI has become the primary objective severity measure in atopic dermatitis clinical trials and is recommended by international regulatory authorities (FDA, EMA). |
| ScholarGateডেটাসেট ↗ |
|
|